雲海金屬(002182.SZ):獲得國家工信部工業轉型升級強基工程項目中央財政第二筆補助資金1838萬元
格隆匯 7 月 1日丨雲海金屬(002182.SZ)公佈,根據《關於下達2020年國家制造業高質量發展資金(工業和信息化領域)計劃的通知》(寧財企[2020]154號),2020年7月1日,公司獲得國家工信部工業轉型升級強基工程項目中央財政第二筆補助資金1838萬元。
工業轉型升級強基工程項目暨“高強鎂合金及其變形加工產品產業化項目”,旨在通過突破高強鎂合金材料製備關鍵技術,形成工程化、產業化能力,滿足我國航空航天、軌道交通、通訊電子等領域對高性能鎂合金材料的需求,主要產品為面向國防軍工等高端裝備使用的高強度鎂合金變形材。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.